Just now!

Tomson By-Health (300146.SZ), a leading domestic health care product in the high-quality track, crashed by 6 points, but rebounded as of midday closing, trading at 15.8 yuan per share, down 5.11%. By-Health has been a good stock since its listing.

An out-and-out super bull stock, it has risen nine times from the low of 2.18 yuan after its listing in 2011 to the high of 21.98 yuan in mid-November 2018.

However, a new regulation has caused "growing pains" for the originally promising growth stocks.

The recently promulgated "Interim Measures for Reporting Rewards for Fraudulent Medical Security Funds" is aimed at the theft of medical security identity certificates and supervises insured persons not to use fraudulent practices to cash out when purchasing nutrition and health care products.

Research report data shows that more than 70% of By-Health’s main products are sold in pharmacies.

The introduction of new regulations has really hurt By-Health. By-Health's stock price has plummeted from a high of around 21 yuan in mid-December to 15.8 yuan at noon on the 8th. The dynamic price-to-earnings ratio is only 16 times. It can be seen that "Mr. Market"

"The lethality is huge.

Tomson By-Health's performance this year estimates that its net profit in 2018 will be 920 million to 1.073 billion, a year-on-year increase of 20%-40%. This year's "report card" can be said to be quite good. However, it is still unknown how much next year's net profit will be affected by the new regulations.

Except for BY-HEALTH, many consumer stocks (food and beverages, excluding liquor) have dynamic price-to-earning ratios of less than 20 times.

For example, the dynamic price-to-earnings ratio of Yuanzu Shares (603886.SH) is only 12.8 times; the dynamic price-to-earnings ratio of Yangyuan Beverage (603156.SH) is only 13.68 times.

Chengde Lulu (000848.SZ) and Shuanghui Development (000893.SZ) both have price-to-earning ratios of less than 17 times.